Brazilian Plasmodium falciparum isolates: Investigation of candidate polymorphisms for artemisinin resistance before introduction of artemisinin-based combination therapy

Malaria Journal

Volumn 9, Issue 1, 2010, Pages

  Gama, Bianca E ^a   De Oliveira, Natália K Almeida ^a   De Souza, José M ^b   Santos, Fátima ^c   De Carvalho, Leonardo J M ^a,d   Melo, Yonne F C ^e   Rosenthal, Philip J ^f   Daniel Ribeiro, Cláudio T ^a   Ferreira Da Cruz, Maria De Fátima ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b INSTITUTO EVANDRO CHAGAS   (Brazil)

^c LACEN   (Brazil)

^d LA JOLLA BIOENGINEERING INSTITUTE   (United States)

^e FUNDAÇÃO DE MEDICINA TROPICAL DR HEITOR VIEIRA DOURADO   (Brazil)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; ARTEMISININ; PROTEIN PFATPASE6; PROTEIN PFMDR1; PROTOZOAL PROTEIN; SERINE; UNCLASSIFIED DRUG; VALINE; ADENOSINE TRIPHOSPHATASE; ARTEMISININ DERIVATIVE; MDR1 PROTEIN, PLASMODIUM FALCIPARUM; MULTIDRUG RESISTANCE PROTEIN; PROTOZOAL DNA;

ADULT; ANTIMALARIAL DRUG RESISTANCE; ARTICLE; BRAZIL; CODON; DNA SEQUENCE; ENDEMIC DISEASE; FEMALE; GENE IDENTIFICATION; GENE MUTATION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALE; MUTANT; PARASITE ISOLATION; PLASMODIUM FALCIPARUM; POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; WILD TYPE; DRUG RESISTANCE; GENETICS; ISOLATION AND PURIFICATION; PARASITOLOGY;

ADENOSINE TRIPHOSPHATASES; ADULT; ANTIMALARIALS; ARTEMISININS; BRAZIL; DNA, PROTOZOAN; DRUG RESISTANCE; GENETIC VARIATION; GENOTYPE; HUMANS; MALARIA, FALCIPARUM; MALE; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; PLASMODIUM FALCIPARUM; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA;

EID: 78649786781     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-9-355     Document Type: Article

References (35)

1. Artemisinin-based combination therapy for treating uncomplicated malaria. D Sinclair B Zani S Donegan P Olliaro P Garner, Cochrane Database Syst Rev 2009 3 D007483 19588433
2. Resistance of Plasmodium falciparum field isolates to in-vitro artemether and point mutations of the SERCA-type PfATPase6. R Jambou E Legrand M Niang N Khim P Lim B Volney M Ekala C Bouchier P Esterre T Fandeur O Mercereau-Puijalon, Lancet 2005 366 1960 1963 10.1016/S0140-6736(05)67787-2 16325698
3. In vitro assessment of artesunate, artemether and amodiaquine susceptibility and molecular analysis of putative resistance-associated mutations of Plasmodium falciparum from So Tomé and Príncipe. I Ferreira D Lopes A Martinelli C Ferreira V do Rosrio P Cravo, Trop Med Int Health 2007 12 353 362 10.1111/j.1365-3156.2006.01789.x 17313506
4. Plasmodium falciparum from Par state (Brazil) shows satisfactory in vitro response to artemisinin derivatives and absence of the S769N mutation in the SERCA-type PfATPase6. I Ferreira A Martinelli L Rodrigues E do Carmo V do Rosrio M Pávoa P Cravo, Trop Med Int Health 2008 13 199 207 10.1111/j.1365-3156.2007.01991.x 18304266
5. Molecular epidemiology of malaria in Cameroon. XXVIII. In vitro activity of dihydroartemisinin against clinical isolates of Plasmodium falciparum and sequence analysis of the P. falciparum ATPase 6 gene. R Tahar P Ringwald L Basco, Am J Trop Med Hyg 2009 81 13 18 19556559
6. Evidence of artemisinin-resistant malaria in western Cambodia. H Noedl Y Se K Schaecher B Smith D Socheat M Fukuda, N Engl J Med 2008 359 2619 2620 10.1056/NEJMc0805011 19064625
7. Artemisinin resistance in Plasmodium falciparum malaria. A Dondorp F Nosten P Yi D Das A Phyo J Tarning K Lwin F Ariey W Hanpithakpong SJ Lee P Ringwald K Silamut M Imwong K Chotivanich P Lim T Herdman SS An S Yeung P Singhasivanon NP Day N Lindegardh D Socheat NJ White, N Engl J Med 2009 361 455 467 10.1056/NEJMoa0808859 19641202
8. Pgh1 modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum. M Reed K Saliba S Caruana K Kirk A Cowman, Nature 2000 403 906 909 10.1038/35002615 10706290
9. Artemisinin: mechanisms of action, resistance and toxicity. S Meshnick, Int J Parasitol 2002 32 1655 1660 10.1016/S0020-7519(02)00194-7 12435450
10. The tyrosine-86 allele of the pfmdr1 gene of Plasmodium falciparum is associated with increased sensitivity to the anti-malarials mefloquine and artemisinin. M Duraisingh P Jones I Sambou L von Seidlein M Pinder D Warhurst, Mol Biochem Parasitol 2000 108 13 23 10.1016/S0166-6851(00)00201-2 10802315 (Pubitemid 30236312)
11. Decreasing pfmdr1 copy number in Plasmodium falciparum malaria heightens susceptibility to mefloquine, lumefantrine, halofantrine, quinine, and artemisinin. A Sidhu A Uhlemann S Valderramos J Valderramos S Krishna D Fidock, J Infect Dis 2006 194 528 535 10.1086/507115 16845638
12. pfmdr1 mutations contribute to quinine resistance and enhance mefloquine and artemisinin sensitivity in Plasmodium falciparum. A Sidhu S Valderramos D Fidock, Mol Microbiol 2005 57 913 926 10.1111/j.1365-2958.2005.04729.x 16091034
13. Resistance to antimalarials in Southeast Asia and genetic polymorphisms in pfmdr1. A Pickard C Wongsrichanalai A Purfield D Kamwendo K Emery C Zalewski F Kawamoto R Miller S Meshnick, Antimicrob Agents Chemother 2003 47 2418 2423 10.1128/AAC.47.8.2418-2423.2003 12878499
14. In vivo selection of Plasmodium falciparum pfmdr1 86N coding alleles by artemether-lumefantrine (Coartem). C Sisowath J Strömberg A Mårtensson M Msellem C Obondo A Björkman J Gil, J Infect Dis 2005 191 1014 1017 10.1086/427997 15717281
15. The role of pfmdr1 in Plasmodium falciparum tolerance to artemether-lumefantrine in Africa. C Sisowath P Ferreira L Bustamante S Dahlström A Mårtensson A Björkman S Krishna J Gil, Trop Med Int Health 2007 12 736 742 10.1111/j.1365-3156.2007.01843.x 17550470
16. Selection of Plasmodium falciparum multidrug resistance gene 1 alleles in asexual stages and gametocytes by artemether-lumefantrine in Nigerian children with uncomplicated falciparum malaria. C Happi G Gbotosho O Folarin A Sowunmi T Hudson M O'Neil W Milhous D Wirth A Oduola, Antimicrob Agents Chemother 2009 53 888 895 10.1128/AAC.00968-08 19075074
17. Selection of Plasmodium falciparum pfmdr1 alleles following therapy with artemether-lumefantrine in an area of Uganda where malaria is highly endemic. C Dokomajilar S Nsobya B Greenhouse P Rosenthal G Dorsey, Antimicrob Agents Chemother 2006 50 1893 1895 10.1128/AAC.50.5.1893-1895.2006 16641472
18. Amodiaquine and artemether-lumefantrine select distinct alleles of the Plasmodium falciparum mdr1 gene in Tanzanian children treated for uncomplicated malaria. G Humphreys I Merinopoulos J Ahmed C Whitty T Mutabingwa C Sutherland R Hallett, Antimicrob Agents Chemother 2007 51 991 997 10.1128/AAC.00875-06 17194834
19. In vivo selection of Plasmodium falciparum parasites carrying the chloroquine-susceptible pfcrt K76 allele after treatment with artemether-lumefantrine in Africa. C Sisowath I Petersen M Veiga A Mårtensson Z Premji A Björkman D Fidock J Gil, J Infect Dis 2009 199 750 757 10.1086/596738 19210165
20. Diversity of the sarco/endoplasmic reticulum Ca(2+)-ATPase orthologue of Plasmodium falciparum (PfATP6). S Dahlström M Veiga P Ferreira A Mårtensson A Kaneko B Andersson A Björkman J Gil, Infect Genet Evol 2008 8 340 345 10.1016/j.meegid.2008.02.002 18359278
21. Artemisinin-resistant Plasmodium falciparum: can the genie be put back in the bottle? T Egan, Future Microbiol 2009 4 637 639 10.2217/fmb.09.42 19659418
22. Characterization of Plasmodium falciparum isolated from the Amazon region of Brazil: evidence for quinine resistance. M Zalis L Pang M Silveira W Milhous D Wirth, Am J Trop Med Hyg 1998 58 630 637 9598453
23. Pfmdr1 Asn1042Asp and Asp1246Tyr polymorphisms, thought to be associated with chloroquine resistance, are present in chloroquine-resistant and -sensitive Brazilian field isolates of Plasmodium falciparum. M Pávoa I Adagu S Oliveira R Machado M Miles D Warhurst, Exp Parasitol 1998 88 64 68 10.1006/expr.1998.4195 9501850
24. Plasmodium falciparum isolates from Angola show the StctVMNT haplotype in the pfcrt gene. B Gama G Pereira-Carvalho F Lutucuta Kosi N Almeida de Oliveira F Fortes P Rosenthal C Daniel-Ribeiro MF Ferreira-da-Cruz, Malar J 2010 9 174 10.1186/1475-2875-9-174 20565881
25. Detection of novel point mutations in the Plasmodium falciparum ATPase6 candidate gene for resistance to artemisinins. M Menegon A Sannella G Majori C Severini, Parasitol Int 2008 57 233 235 10.1016/j.parint.2007.12.004 18187359
26. ChromaPipe: a pipeline for analysis, quality control and management for a DNA sequencing facility. T Otto E Vasconcellos L Gomes A Moreira W Degrave L Mendonça-Lima M Alves-Ferreira, Genet Mol Res 2008 7 861 871 10.4238/vol7-3X-Meeting04 18949705
27. Malaria diagnosis: standardization of a polymerase chain reaction for the detection of Plasmodium falciparum parasites in individuals with low-grade parasitemia. M Zalis M Ferreira-da-Cruz H Balthazar-Guedes D Banic W Alecrim J Souza P Druilhe C Daniel-Ribeiro, Parasitol Res 1996 82 612 616 10.1007/s004360050173 8875568
28. Intrahost selection of Plasmodium falciparum pfmdr1 alleles after antimalarial treatment on the northwestern border of Thailand. A Uhlemann R McGready E Ashley A Brockman P Singhasivanon S Krishna N White F Nosten R Price, J Infect Dis 2007 195 134 141 10.1086/509809 17152017
29. Molecular monitoring of Plasmodium falciparum resistance to artemisinin in Tanzania. K Mugittu B Genton H Mshinda H Beck, Malar J 2006 5 126 10.1186/1475-2875-5-126 17177997
30. Short report: polymorphisms in the pfcrt and pfmdr1 genes of Plasmodium falciparum and in vitro susceptibility to amodiaquine and desethylamodiaquine. D Echeverry G Holmgren C Murillo J Higuita A Björkman J Gil L Osorio, Am J Trop Med Hyg 2007 77 1034 1038 18165517
31. Discordant patterns of genetic variation at two chloroquine resistance loci in worldwide populations of the malaria parasite Plasmodium falciparum. R Mehlotra G Mattera M Bockarie J Maguire J Baird Y Sharma M Alifrangis G Dorsey P Rosenthal D Fryauff JW Kazura M Stoneking PA Zimmerman, Antimicrob Agents Chemother 2008 52 2212 2222 10.1128/AAC.00089-08 18411325
32. Polymorphism of PfATPase in Niger: detection of three new point mutations. M Ibrahim N Khim H Adam F Ariey J Duchemin, Malar J 2009 8 28 10.1186/1475-2875-8-28 19226462
33. Geographic structuring of the Plasmodium falciparum sarco(endo)plasmic reticulum Ca2+ ATPase (PfSERCA) gene diversity. R Jambou A Martinelli J Pinto S Gribaldo E Legrand M Niang N Kim L Pharath B Volnay M Ekala C Bouchier T Fandeur P Berzosa A Benito ID Ferreira C Ferreira PP Vieira MG Alecrim O Mercereau-Puijalon P Cravo, PLoS One 2010 5 9424 10.1371/journal.pone.0009424 20195531
34. Exploring the contribution of candidate genes to artemisinin resistance in Plasmodium falciparum. M Imwong A Dondorp F Nosten P Yi M Mungthin S Hanchana D Das A Phyo K Lwin S Pukrittayakamee SJ Lee S Saisung K Koecharoen C Nguon NP Day D Socheat NJ White, Antimicrob Agents Chemother 2010 54 2886 2892 10.1128/AAC.00032-10 20421395
35. Increased tolerance to artemisinin in Plasmodium falciparum is mediated by a quiescence mechanism. B Witkowski J Lelièvre M Barragn V Laurent X Su A Berry F Benoit-Vical, Antimicrob Agents Chemother 2010 54 1872 1877 10.1128/AAC.01636-09 20160056